Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
about
Lysosomal sorting of amyloid-β by the SORLA receptor is impaired by a familial Alzheimer's disease mutationModeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future ConcernsApolipoprotein E: from cardiovascular disease to neurodegenerative disordersImpaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1The pericyte: a forgotten cell type with important implications for Alzheimer's disease?Vascular contributions to cognitive impairment and dementia including Alzheimer's diseaseCerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's diseaseAssociation of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.Lymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?Cerebral vascular leak in a mouse model of amyloid neuropathology.Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.The genetics of dementia.Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdownAssociations between apolipoprotein E genotypes and serum levels of glucose, cholesterol, and triglycerides in a cognitively normal aging Han Chinese population.Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging StudyNuclear receptors in neurodegenerative diseases.Cholesterol in brain disease: sometimes determinant and frequently implicated.Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in miceGP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion.Clinical and imaging features of mixed Alzheimer and vascular pathologies.Extracellular proteolysis of apolipoprotein E (apoE) by secreted serine neuronal proteaseEffects of shenque moxibustion on behavioral changes and brain oxidative state in apolipoprotein e-deficient mice.Apolipoprotein E, carbon dioxide vasoreactivity, and cognition in older adults: effect of hypertension.ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriersApolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction.Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins.Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions.Establishment and Dysfunction of the Blood-Brain Barrier.Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APPAPOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function.Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers.A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 MiceMolecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study.Age and its association with low insulin and high amyloid-β peptides in bloodThe Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline.Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's diseaseAssociation between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years.
P2860
Q24337087-9D489F33-3799-471E-B386-3F29AB3607BAQ26745513-54CDBDF3-D29B-43C0-A51B-F6F558F65040Q26747482-F7ACCB26-929E-4678-B44E-9ABA01E86E95Q26800063-40A69212-ECEA-4A23-83D7-FD199527EF48Q26852369-960623C4-DCB1-46D1-9B55-51DF5D9178CFQ26852882-6C102D77-C41E-48C8-A174-ACEFFEAED4E8Q28087176-BD7B44C6-8A4D-4570-B5AB-F494E7D5DC49Q30238885-26D28305-C31A-4715-B4F9-354450155CF8Q30275974-7CCA8FDC-282D-4596-B3AE-52CC86AAEF03Q30609094-D1B08B35-4B89-4014-8CA2-5936FE65FC56Q33575184-4A59D6CA-CA34-4163-901A-874E4668B591Q33626351-5907CF0B-10C4-4981-8497-CF3902A9D014Q33717021-3D8D8413-FF89-4EBA-9BB0-E89539AEEC15Q33895412-260A4CCF-14D8-4E88-BA48-3DEE27D12A20Q34109230-04830772-53B6-458B-BE41-FF6BF74E36D8Q34580020-65BBA709-3546-4F93-B987-78F664C96C07Q34621446-E42360E5-C35E-4715-BEE9-683041E33A1BQ34976193-A65EF82C-C2DC-46FF-A9F1-B023D427E3ABQ35114636-962A840B-F6BC-49FF-85DD-1B29AA5E7C6FQ35125123-438B9925-A89C-43EE-B525-5D4783C21D83Q35133505-8BB95767-7C24-412C-B9D4-B07EDCB850EEQ35155953-5B8F4E3E-6C81-4589-AEDA-D970EF47ADC9Q35222628-92397C25-E844-4C67-A3D9-98E83ABDD55CQ35572281-A592B625-C9EC-4457-ABBF-91E0EE606F29Q35662397-A85303D3-2A30-4339-97C3-5655ED446AD6Q35825824-C94121B6-21ED-40C1-A5F2-BD26D692E20FQ36185793-6748F6DA-2103-4830-83D8-66B51B737463Q36269130-FAEDBA9C-A18D-469B-A87D-5C52D4D923B4Q36306827-451379AD-180A-4BA3-88B7-F37D5624CC65Q36593230-44C44FF5-2BCC-4E4C-AC3E-1891E287DA4FQ36594552-F939386D-8E17-40CF-81DF-3D06374EBB4EQ36659056-1872CB25-1D71-46E5-B283-B36094E47E2EQ36692478-0297BF02-1C47-4431-A966-5E76C0EDCC0CQ36724664-C157BB86-019B-4AEC-B44A-8CB42F5C96FDQ36771721-16802420-1BB0-46B8-9DB3-79091C038C3DQ36787319-6EA21E96-50B8-4F86-961E-0D204056E095Q36809956-8B3460E2-0FB5-41F4-B01F-8EBF915845DCQ36877518-E30DD04B-CA9D-4EAA-8DDF-DA5597026BFBQ37208538-691BC277-3CBA-40D0-8A35-C77BF2A6C44CQ37306445-9AB786C5-72E1-4BA5-A3D8-279D3AEA414A
P2860
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@ast
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@en
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@nl
type
label
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@ast
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@en
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@nl
prefLabel
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@ast
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@en
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@nl
P2860
P3181
P1433
P1476
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease
@en
P2093
Berislav V. Zlokovic
P2860
P3181
P356
10.1001/JAMANEUROL.2013.2152
P407
P577
2013-04-01T00:00:00Z